Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients
Public ClinicalTrials.gov record NCT01601236. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adaptive Design Pilot Safety and Efficacy Study of H.P. Acthar Gel (Acthar) in Patients With Diabetic Nephropathy and Proteinuria.
Study identification
- NCT ID
- NCT01601236
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Mallinckrodt
- Industry
- Enrollment
- 34 participants
Conditions and interventions
Conditions
Interventions
- Repository Corticotropin Injection Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2012
- Primary completion
- Dec 31, 2015
- Completion
- Feb 29, 2016
- Last update posted
- Nov 17, 2019
2012 – 2016
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Questcor Investigational Site | Roseville | California | 95661 | — |
| Questcor Investigational Site | Cooper City | Florida | 33024 | — |
| Questcor Investigational Site | Miami Springs | Florida | 33166 | — |
| Questcor Investigational Site | The Bronx | New York | 10461 | — |
| Questcor Investigational Site | Columbus | Ohio | 43210 | — |
| Questcor Investigational Site | Bethlehem | Pennsylvania | 18017 | — |
| Questcor Investigational Site | Chattanooga | Tennessee | 37408 | — |
| Questcor Investigational Site | Greenville | Texas | 75402 | — |
| Questcor Investigational Site | Houston | Texas | 77030 | — |
| Questcor Investigational Site | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01601236, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 17, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01601236 live on ClinicalTrials.gov.